Doyle John Brendan 4
4 · COGNITION THERAPEUTICS INC · Filed Jul 31, 2025
Insider Transaction Report
Form 4
Doyle John Brendan
Chief Financial Officer
Transactions
- Tax Payment
Common Stock
2025-07-29$0.67/sh−9,360$6,273→ 425,350 total - Award
Common Stock
2025-07-29+30,000→ 434,710 total
Footnotes (2)
- [F1]Shares earned upon the vesting of performance stock units ("PSUs") granted to the Reporting Person on February 14, 2024. Each PSU represents a contingent right to receive one share of the Issuer's Common Stock upon the achievement of certain performance goals. 50% of the total number of shares subject to the PSUs vested on July 29, 2025.
- [F2]Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of PSUs.